ArticleJournal of controlled release : official journal of the Controlled Release Society2017

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Naomi O Hodgins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.